Norgine: Valuation, Funding & Investors
Norgine is a European specialty pharmaceutical company focused on the development, manufacturing and commercialization of medicines for gastroenterology and other specialty therapeutic areas. The company operates manufacturing sites across Europe and supplies medicines across the UK and Europe, emphasizing reliable supply, manufacturing innovation, and quality control.
Leadership & Board
- Current Number of Employees
- 1,183
- Current LinkedIn Followers
- 94,453
Latest Estimated Valuation
- Total Amount Raised
- $23M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $23M
- Latest Funding Round
- Investment
Employee Trend
Norgine had 1,183 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Norgine had 94,453 followers as of November 2, 2026. The number of followers increased by 223 (0.24%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 05, 2026 | Investment | $23.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| UK Government Life Sciences Innovative Manufacturing Fund | Investment |
Similar Companies
A snapshot of private companies similar to Norgine, helping you discover and navigate related company profiles.
Related News and Analysis
